mRNA vaccines against H10N8 and H7N9 influenza viruses of pandemic potential are immunogenic and well tolerated in healthy adults in phase 1 randomized clinical trials-Reference-Cited by-同舟云学术

mRNA vaccines against H10N8 and H7N9 influenza viruses of pandemic potential are immunogenic and well tolerated in healthy adults in phase 1 randomized clinical trials

Published:2019-05 Issue:25 Volume:37 Page:3326-3334
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Feldman Robert A.,Fuhr Rainard,Smolenov Igor,(Mick) Ribeiro Amilcar,Panther Lori,Watson Mike^ORCID,Senn Joseph J.,Smith Mike,Almarsson Ӧrn,Pujar Hari S.,Laska Michael E.,Thompson James,Zaks Tal,Ciaramella Giuseppe

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference39 articles.

1. Zoonotic infections with avian influenza A viruses and vaccine preparedness: a game of “mix and match”;Pascua;Clin Exp Vaccine Res,2014

2. Receptor binding by H10 influenza viruses;Vachieri;Nature,2014

3. Human infection with a novel avian-origin influenza A (H7N9) virus;Gao;N Engl J Med,2013

4. Human cases of influenza at the human-animal interface, January 2015-April 2017;World Health Organization;Wkly Epidemiol Rec,2017

5. Human infection with highly pathogenic avian influenza A(H7N9) virus;Ke;China. Emerg Infect Dis,2017

Cited by 350 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comprehensive analysis of lipid nanoparticle formulation and preparation for RNA delivery;International Journal of Pharmaceutics: X;2024-12

2. mRNA vaccines contribute to innate and adaptive immunity to enhance immune response in vivo;Biomaterials;2024-10

3. A decavalent composite mRNA vaccine against both influenza and COVID-19;mBio;2024-09-11

4. Multimodal profiling of biostabilized human skin modules reveals a coordinated ecosystem response to injected mRNA‐1273 COVID‐19 vaccine;Allergy;2024-08-19

5. Advancement in the development of mRNA‐based vaccines for respiratory viruses;Immunology;2024-08-19